| | Multiple mutations in desmosomal proteins encoding genes in arrhythmogenic right ventricular cardiomyopathy/dysplasiaReceived 23 June 2009; accepted 26 September 2009. published online 12 October 2009. BackgroundArrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a progressive cardiomyopathy showing a wide clinical spectrum in terms of clinical expressions and prognoses. ObjectiveThis study sought to estimate the occurrence of compound and double heterozygotes for mutations in desmosomal proteins encoding genes in a cohort of ARVC/D Italian index cases, and to assess the clinical phenotype of mutations carriers. MethodsFourty-two consecutive ARVC/D index cases who fulfilled the International Task Force diagnostic criteria were screened for mutations in PKP2, DSP, DSG2, DSC2, and JUP genes by denaturing high-performance liquid chromatography (DHPLC) and direct sequencing. ResultsThree probands (7.1%) showing a family history of sudden death carried multiple mutations. Family screening identified an additional 7 multiple-mutation carriers. Among the 7 double heterozygotes for mutations in different genes, 2 were clinically unaffected, 2 were affected, and 3 showed some clinical signs of ARVC/D even if they did not fulfill the diagnostic criteria. Two compound heterozygotes for mutations in the same gene and 1 subject carrying 3 different mutations showed a severe form of the disease with heart failure onset at a young age. Moreover, multiple-mutation carriers showed a higher prevalence of left ventricular involvement (P = .025) than single-mutation carriers. ConclusionOccurrence of compound and double heterozygotes in ARVC/D index cases is particularly relevant to mutation screening strategy and to genetic counseling. Even if multiple-mutation carriers show a wide variability in clinical expression, the extent of the disease is higher compared to that in single-mutation carriers. Abbreviations: ARVC/D, arrhythmogenic right ventricular cardiomyopathy/dysplasia, ECG, electrocardiogram, DHPLC, denaturing high-performance liquid chromatography, ICD, implantable cardioverter-defibrillator, RPD, repeat domains, RV, right ventricular, VT, ventricular tachycardia ⁎ Department of Cardiac-Thoracic and Vascular Sciences, University of Padua Medical School, Padua, Italy † Department of Biology, University of Padua, Padua, Italy ‡ Department of Medical-Diagnostic Sciences and Special Therapies, University of Padua Medical School, Padua, Italy § Department of Pediatrics, Section of Cardiology, Baylor College of Medicine, Houston, Texas Address reprint requests and correspondence: Dr. Alessandra Rampazzo, Department of Biology, University of Padua, Via U. Bassi 58/B, 35131 Padua, Italy
This study was supported by Telethon, Rome, Italy (GGP07220 and GGP05261); Fifth Framework Program European Commission (QLG1-CT-2000-01091), Bruxelles, Belgium; National Institutes of Health (U04HL 65652), Bethesda, Maryland, USA; Ministry of Health, MIUR (2006061007_002), Rome, Italy; and Fondazione CA.RI.PA.RO, Padua, Italy. PII: S1547-5271(09)01145-X doi:10.1016/j.hrthm.2009.09.070 © 2010 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved. | |
|